المؤلفون: Qvortrup, C, Jensen, BV, Fokstuen, T, Nielsen, SE, Keldsen, N, Glimelius, B, Bjerregaard, B, Mejer, J, Larsen, FO, Pfeiffer, P

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 21(1):87-91

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:119776273

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Markussen A; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Johansen JS; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Medicine, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark., Larsen FO; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Theile S; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Hasselby JP; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Willemoe GL; Department of Pathology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark., Lorentzen T; Department of Gastroenterology, Unit of Surgical Ultrasound, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Madsen K; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Høgdall E; Department of Pathology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Poulsen TS; Department of Pathology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Wilken EE; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Geertsen P; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Behrens CP; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Roskilde, Denmark., Svane IM; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark., Nielsen D; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark., Chen IM; Department of Oncology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3428-3437.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Radiosurgery*/methods , Radiosurgery*/adverse effects , Nivolumab*/administration & dosage , Nivolumab*/therapeutic use , Biliary Tract Neoplasms*/pathology , Biliary Tract Neoplasms*/therapy , Biliary Tract Neoplasms*/drug therapy , Biliary Tract Neoplasms*/mortality , Ipilimumab*/administration & dosage , Ipilimumab*/therapeutic use, Humans ; Female ; Male ; Aged ; Middle Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aged, 80 and over ; Combined Modality Therapy